Biotech · Private company
Umoja Biopharma
Track this companyFree. Adds Umoja Biopharma to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Rapamycin (sirolimus)Phase 2 · Lymphoma, B CellClinicalTrials.gov · fetched Nov 12, 2026
- UB-VV400Phase 2 · Lymphoma, B CellClinicalTrials.gov · fetched Nov 12, 2026
- rapamycinPhase 1 · Lymphoma, B-CellClinicalTrials.gov · fetched Nov 12, 2026
- UB-VV111Phase 1 · Lymphoma, B-CellClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell MalignanciesPHASE1_PHASE2 · RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07735533 · fetched Nov 12, 2026
- A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell MalignanciesPHASE1 · RECRUITING · started Mar 10, 2025ClinicalTrials.gov NCT06528301 · fetched Nov 12, 2026
- A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic SarcomaPHASE1 · ACTIVE_NOT_RECRUITING · started May 20, 2022ClinicalTrials.gov NCT05312411 · fetched Nov 12, 2026